ATE433957T1 - Amphiphilische trisulphonierte porphyrazine zur photodynamischen medizinischen anwendung - Google Patents

Amphiphilische trisulphonierte porphyrazine zur photodynamischen medizinischen anwendung

Info

Publication number
ATE433957T1
ATE433957T1 AT04732902T AT04732902T ATE433957T1 AT E433957 T1 ATE433957 T1 AT E433957T1 AT 04732902 T AT04732902 T AT 04732902T AT 04732902 T AT04732902 T AT 04732902T AT E433957 T1 ATE433957 T1 AT E433957T1
Authority
AT
Austria
Prior art keywords
amphiphilic
trisulphonated
porphyrazine
medical use
porphyrazines
Prior art date
Application number
AT04732902T
Other languages
English (en)
Inventor
Lier Johannes E Van
Haroutioun Minas Hassessian
Hongjian Tian
Nicole Cauchon
Hasrat Ali
Original Assignee
Univ Sherbrooke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sherbrooke filed Critical Univ Sherbrooke
Application granted granted Critical
Publication of ATE433957T1 publication Critical patent/ATE433957T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/045—Special non-pigmentary uses, e.g. catalyst, photosensitisers of phthalocyanine dyes or pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C09B47/0678—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile having-COOH or -SO3H radicals or derivatives thereof directly linked to the skeleton
AT04732902T 2003-05-14 2004-05-14 Amphiphilische trisulphonierte porphyrazine zur photodynamischen medizinischen anwendung ATE433957T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47019703P 2003-05-14 2003-05-14
PCT/CA2004/000739 WO2004101516A2 (en) 2003-05-14 2004-05-14 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine

Publications (1)

Publication Number Publication Date
ATE433957T1 true ATE433957T1 (de) 2009-07-15

Family

ID=33452378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04732902T ATE433957T1 (de) 2003-05-14 2004-05-14 Amphiphilische trisulphonierte porphyrazine zur photodynamischen medizinischen anwendung

Country Status (12)

Country Link
US (1) US7541457B2 (de)
EP (1) EP1628958B1 (de)
JP (1) JP4855937B2 (de)
CN (1) CN1823038B (de)
AT (1) ATE433957T1 (de)
AU (1) AU2004238410B2 (de)
CA (1) CA2525447C (de)
DE (1) DE602004021591D1 (de)
MX (1) MXPA05012165A (de)
NZ (1) NZ543565A (de)
RU (1) RU2367653C2 (de)
WO (1) WO2004101516A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2340041A2 (de) * 2008-09-08 2011-07-06 Hoffman/Barrett, L.L.C. Optische und dual-optische/mr-kontrastmittel und therakeutika mit porphyrazinen
GB0914286D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Method
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756541A (en) * 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
US5864044A (en) * 1997-07-24 1999-01-26 Universite De Sherbrooke Syntheses of trisulfonated phthalocyanines and their derivatatives using boron (111) subphthalocyanines as intermediates
HUP0301099A3 (en) * 1999-12-08 2003-11-28 Gentian As Substituted phthalocyanines and their precursors

Also Published As

Publication number Publication date
WO2004101516A3 (en) 2005-09-15
WO2004101516A2 (en) 2004-11-25
RU2005138867A (ru) 2006-06-27
CA2525447A1 (en) 2004-11-25
CN1823038B (zh) 2010-05-12
MXPA05012165A (es) 2006-05-19
EP1628958B1 (de) 2009-06-17
US20060282038A1 (en) 2006-12-14
CN1823038A (zh) 2006-08-23
CA2525447C (en) 2013-08-06
RU2367653C2 (ru) 2009-09-20
JP4855937B2 (ja) 2012-01-18
EP1628958A2 (de) 2006-03-01
JP2006528665A (ja) 2006-12-21
NZ543565A (en) 2008-12-24
AU2004238410A1 (en) 2004-11-25
US7541457B2 (en) 2009-06-02
AU2004238410B2 (en) 2010-07-29
DE602004021591D1 (de) 2009-07-30

Similar Documents

Publication Publication Date Title
CY1113039T1 (el) Ηλεκτρικο και μηλονικο αλας τρανς-4-(1r,3s)-6-χλωρο-3-φαινυλινδαν-1-υλο)-1,2,2-τριμεθυλοπιπεραζινης και η χρηση ως φαρμακο
DE60303238D1 (de) Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
DE50310516D1 (de) Fredericamycin-derivate
CY1117030T1 (el) Τροποποιηση της εκφρασης απολιποπρωτεϊνης c-iii
ATE534730T1 (de) Diagnose und behandlung von multiplen sulfatase- erkrankungen und anderen mit hilfe eines formylglycin bildenden enzyms
CY1108514T1 (el) Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
ECSP066311A (es) Derivados de la piperazina y su uso como agentes terapéuticos
ATE370139T1 (de) Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs
ATE312103T1 (de) Substituierte porphyrine und deren therapeutische verwendungen
BRPI0409198A (pt) derivados quinolin-2-ona para o tratamento de doenças de vias aéreas
CY1109348T1 (el) Διυδρο-θειενο-πυριμιδινες για τη θεραπεια φλεγμονωδων παθησεων
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
MA27880A1 (fr) Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
ATE508114T1 (de) Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
DE60331185D1 (de) Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
EA201001365A1 (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-b]ПИРИДАЗИНА, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, ОПОСРЕДУЕМОГО C-МЕТ ТИРОЗИНКИНАЗОЙ
BRPI0818581A2 (pt) Carboxamidas n-fenil-bipirrolidina substituídas e uso terapêutico das mesmas
CY1108324T1 (el) Νεοι τεταρτοταγοποιημενοι εστερες κουινουκλιδινης
NO20064894L (no) Beta-karboliner anvendbare for behandling av inflammatoriske sykdommer
ATE259814T1 (de) Substituierte metallphthalocyaninen, ihre herstellung und verwendung
ATE393775T1 (de) Verfahren zur herstellung von aplidin und neue antitumoralen derivate, verfahren zu deren herstellung und zu deren verwendung
ATE306281T1 (de) Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs
WO2004004641A3 (en) PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPα SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1628958

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1628958

Country of ref document: EP

EEIH Change in the person of patent owner